Close Menu

James Le Fanu, a physician by trade, suggests in a Prospect magazine editorial that "for science this is both the best and the worst of times." It is the "best," he says, because "its research institutions have never been so impressive, its funding never more lavish." But the "worst," he adds, because the scientific achievements "of the recent past have been rather disappointing," when compared with those from the beginning of the 20th century.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.